Consolidated Statements of Changes in Shareholders’ Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock	Common Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjusted Balance	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2022				31,346,903
Balance at beginning of period at Dec. 31, 2022	$ 1,228,321			$ 310		$ 412,303			$ 1,015,215			$ (199,507)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	100,534								100,534
Other comprehensive income (loss), net of tax	37,150											37,150
Stock-based compensation expense	10,018					10,018
Issuance of common stock under share-based compensation arrangements (in shares)				157,560
Issuance of common stock under share-based compensation arrangements	0			$ 1		(1)
Issuance of common stock related to employee stock purchase plan (in shares)				21,149
Issuance of common stock related to employee stock purchase plan	586					586
Cash dividends declared	(54,293)								(54,293)
Common stock repurchased (in shares)				(1,600,000)
Common stock repurchased	(48,033)			$ (15)		(48,018)
Ending balance (in shares) at Dec. 31, 2023				29,925,612
Balance at end of period at Dec. 31, 2023	1,274,283			$ 296		374,888			1,061,456			(162,357)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	(47,035)								(47,035)
Other comprehensive income (loss), net of tax	20,884											20,884
Stock-based compensation expense	9,561					9,561
Issuance of common stock under share-based compensation arrangements (in shares)				252,576
Issuance of common stock under share-based compensation arrangements	0			$ 2		(2)
Issuance of common stock related to employee stock purchase plan (in shares)				23,815
Issuance of common stock related to employee stock purchase plan	485					485
Cash dividends declared	(32,117)								(32,117)
Common stock repurchased	$ 0
Ending balance (in shares) at Dec. 31, 2024	30,202,003			30,202,003	30,202,003
Balance at end of period at Dec. 31, 2024	$ 1,226,061	$ 0	$ 1,226,061	$ 298	$ 298	384,932	$ (8,705)	$ 376,227	982,304	$ 8,705	$ 991,009	(141,473)	$ (141,473)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	(138,052)								(138,052)
Other comprehensive income (loss), net of tax	52,314											52,314
Stock-based compensation expense	7,046					7,046
Issuance of common stock under share-based compensation arrangements (in shares)				136,449
Issuance of common stock under share-based compensation arrangements	(1,208)			$ 2		(1,210)
Issuance of common stock related to employee stock purchase plan (in shares)				21,180
Issuance of common stock related to employee stock purchase plan	436					436
Cash dividends declared	(15,314)								(15,314)
Common stock repurchased	$ 0
Ending balance (in shares) at Dec. 31, 2025	30,359,632			30,359,632
Balance at end of period at Dec. 31, 2025	$ 1,131,283			$ 300		$ 382,499			$ 837,643			$ (89,159)